Search

everythinglearnresearchcommunity

for

Search:↓

Swellable microneedles could improve drug delivery and diagnostics but need more research on materials and technology integration.

Microneedles combined with conventional therapies show promise in treating alopecia areata.

A new method using Platelet-rich Plasma (PRP) in a microneedle can promote hair regrowth more efficiently and is painless, minimally invasive, and affordable.

Dissolving microneedles show promise for delivering medication through the skin but face challenges like manufacturing complexity and regulatory hurdles.

Microneedles are a promising method for drug delivery, offering efficient and convenient alternatives with fewer side effects.

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.

Microneedles improve drug delivery for skin diseases, enhancing treatment effectiveness and patient compliance.

Microneedles offer a promising, less invasive way to treat and monitor psoriasis.

The new treatment using microneedle patches shows promise for better hair growth in androgenetic alopecia.

Oral testosterone therapy raises heart risk more than other methods.

Common skin conditions can greatly affect a person's mental health and social life.

Microneedling helps with hair loss, especially with 5% minoxidil, but more high-quality research is needed.

Hyaluronic acid injections can cause temporary hair loss, but hair can regrow with early treatment.

Combining microneedling with triamcinolone acetonide is more effective for treating alopecia areata than microneedling alone.

New skin disease treatments using TDDS are improving but face challenges like side effects and high costs.

Dermoscopy can help assess the severity of chronic radiation-induced skin damage in head and neck cancer patients.

TFC-loaded microneedles effectively promote hair regrowth in androgenetic alopecia.

Antioxidant nanoparticles show promise for treating inflammatory diseases but need more research for safe and effective use.

Schimmelpenning Syndrome requires careful evaluation and tailored treatment for skin, eye, and developmental issues.

New method improves copper peptide delivery for hair growth three times better than current options.

Early intervention in patch-type alopecia may prevent progression to more severe forms by targeting immune pathways and preserving keratin.

Cosmeceuticals like sunscreens may trigger frontal fibrosing alopecia, but more research is needed.

A new gene mutation may allow some piebaldism patients to regain skin color in white patches.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

A rabbit with sebaceous adenitis was effectively treated with ciclosporin and medium-chain triglycerides.

Hair loss due to syphilis can be identified using trichoscopy and is treatable with antibiotics.

Transcutol® helps drugs penetrate the skin more effectively in various formulations.

UVA1-light therapy successfully treated a child's skin condition, mycosis fungoides.

Alopecia areata in infants may be more common than previously thought.

Certain drugs increase calcium levels in cancer cells by triggering internal calcium release.